NCT06136897 2026-03-18
Testing Trastuzumab and Pertuzumab in Patients With Higher Than Normal Copies of the HER2 Gene Found in Their Tumors (MATCH - Subprotocol J)
National Cancer Institute (NCI)
Phase 2 Active not recruiting
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
Eastern Cooperative Oncology Group
SWOG Cancer Research Network
NRG Oncology
Mayo Clinic
Mayo Clinic
SWOG Cancer Research Network
Roswell Park Cancer Institute
Thomas Jefferson University
Emory University
National Cancer Institute (NCI)
M.D. Anderson Cancer Center